NM_001145712.2:c.16G>C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145712.2(NUPR2):c.16G>C(p.Glu6Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000207 in 1,452,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145712.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151826Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000500 AC: 3AN: 60048Hom.: 0 AF XY: 0.0000286 AC XY: 1AN XY: 34992
GnomAD4 exome AF: 0.0000200 AC: 26AN: 1300762Hom.: 0 Cov.: 31 AF XY: 0.0000219 AC XY: 14AN XY: 640346
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151826Hom.: 0 Cov.: 31 AF XY: 0.0000405 AC XY: 3AN XY: 74164
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.16G>C (p.E6Q) alteration is located in exon 1 (coding exon 1) of the NUPR2 gene. This alteration results from a G to C substitution at nucleotide position 16, causing the glutamic acid (E) at amino acid position 6 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at